Cash flow Rorze Corporation

Equities

6323

JP3982200002

Semiconductor Equipment & Testing

Market Closed - Japan Exchange Other stock markets 01:30:00 2025-12-12 am EST			5-day change	1st Jan Change
2,147.50 ^JPY	-0.56%		-2.39%	+40.36%

Oct. 10	Rorze's Attributable Profit Drops 31% in Fiscal H1	MT
Aug. 01	Tranche Update on Rorze Corporation's Equity Buyback Plan announced on April 11, 2025.	CI

e8b8d3c25aadb.TIsoegDuVlywBoMHx9tMN2Uao64ejP5bI4ArKqPFKs0.C7tNIkSZbhvkbPNxiqIUWxx3zu1x6s4jd-56Q5aKE7gc3AU0OKokK-lLxg

Published financial data: RORZE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: February	2021	2022	2023	2024	2025
Revenues	50.8B	67B	94.52B	93.25B	124B
Total Revenues	50.8B	67B	94.52B	93.25B	124B
Cost of Goods Sold, Total	36.08B	44.36B	59.71B	57.99B	74.79B
Gross Profit	14.72B	22.64B	34.81B	35.26B	49.62B
Selling General & Admin Expenses, Total	4.51B	5.28B	6.71B	9.33B	15.27B
Provision for Bad Debts	-61M	-4M	-42M	-1M	122M
R&D Expenses	418M	871M	911M	1.02B	1.24B
Depreciation & Amortization - (IS)	200M	217M	277M	298M	481M
Other Operating Expenses	339M	461M	535M	475M	480M
Other Operating Expenses, Total	5.41B	6.83B	8.39B	11.12B	17.59B
Operating Income	9.31B	15.81B	26.42B	24.14B	32.02B
Interest Expense, Total	-44M	-38M	-49M	-70M	-100M
Interest And Investment Income	12M	19M	27M	148M	618M
Net Interest Expenses	-32M	-19M	-22M	78M	518M
Currency Exchange Gains (Loss)	-1.13B	2.18B	3.95B	2.72B	3.32B
Other Non Operating Income (Expenses)	131M	57M	287M	265M	419M
EBT, Excl. Unusual Items	8.29B	18.02B	30.63B	27.2B	36.28B
Gain (Loss) On Sale Of Investments	447M	-68M	-	-	-2.17B
Gain (Loss) On Sale Of Assets	9M	881M	14M	2M	-
Asset Writedown	200M	-351M	-294M	-135M	-1.14B
Other Unusual Items	0	-1M	-	-1M	-409M
EBT, Incl. Unusual Items	8.94B	18.48B	30.35B	27.06B	32.56B
Income Tax Expense	2.02B	4.66B	7.65B	6.98B	9.42B
Earnings From Continuing Operations	6.92B	13.82B	22.7B	20.09B	23.14B
Net Income to Company	6.92B	13.82B	22.7B	20.09B	23.14B
Minority Interest	-452M	-999M	-1.31B	-512M	496M
Net Income - (IS)	6.47B	12.82B	21.38B	19.58B	23.63B
Net Income to Common Incl Extra Items	6.47B	12.82B	21.38B	19.58B	23.63B
Net Income to Common Excl. Extra Items	6.47B	12.82B	21.38B	19.58B	23.63B
Per Share Items
Net EPS - Basic	37.44	74.21	123.74	111.11	134.08
Basic EPS - Continuing Operations	37.44	74.21	123.74	111.11	134.08
Basic Weighted Average Shares Outstanding	173M	173M	173M	176M	176M
Net EPS - Diluted	37.38	74.07	123.51	110.91	133.99
Diluted EPS - Continuing Operations	37.38	74.07	123.51	110.91	133.99
Diluted Weighted Average Shares Outstanding	173M	173M	173M	177M	176M
Normalized Basic EPS	27.36	59.4	103.18	93.58	131.44
Normalized Diluted EPS	27.31	59.29	102.99	93.4	131.35
Dividend Per Share	-	6.5	13.5	13.5	17
Payout Ratio	8.01	4.04	5.25	11.91	10.06
Supplemental Items
EBITDA	10.6B	17.33B	28.4B	26.94B	36.56B
EBITA	9.31B	15.81B	26.42B	24.4B	33.72B
EBIT	9.31B	15.81B	26.42B	24.14B	32.02B
Effective Tax Rate - (Ratio)	22.6	25.22	25.22	25.78	28.94
Normalized Net Income	4.73B	10.27B	17.83B	16.49B	23.17B
Non-Cash Pension Expense	178M	94.38M	17M	227M	256M
Supplemental Operating Expense Items
General and Administrative Expenses	254M	339M	401M	469M	494M
Research And Development Expense From Footnotes	418M	871M	911M	1.02B	1.24B

Fiscal Period: February	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	16.82B	23.63B	28.29B	37.95B	62.99B
Total Cash And Short Term Investments	16.82B	23.63B	28.29B	37.95B	62.99B
Accounts Receivable, Total	11.29B	18.86B	26.71B	26.45B	30.56B
Total Receivables	11.29B	18.86B	26.71B	26.45B	30.56B
Inventory	11.12B	22.42B	42.83B	53.28B	49.16B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	716M	1.54B	2.15B	2.46B	2.82B
Total Current Assets	39.94B	66.46B	99.99B	120B	146B
Net Property Plant And Equipment	16.66B	17.48B	22.1B	22.62B	24.45B
Long-term Investments	1.16B	1.69B	2.45B	4.45B	2.72B
Goodwill	-	-	-	2.32B	9.64B
Other Intangibles, Total	543M	614M	643M	2.9B	2.97B
Loans Receivable Long-Term	274M	274M	5M	1.74B	500M
Deferred Tax Assets Long-Term	955M	1.77B	1.29B	1.96B	1.94B
Other Long-Term Assets, Total	2M	1M	2M	1M	2M
Total Assets	59.53B	88.29B	126B	156B	188B
Liabilities
Accounts Payable, Total	2.62B	6.85B	7.35B	6.39B	7.68B
Accrued Expenses, Total	748M	925M	1.09B	1.36B	1.9B
Short-term Borrowings	11.47B	11.92B	14.94B	16.34B	14.95B
Current Portion of Leases	2M	1M	-	3M	5M
Current Income Taxes Payable	1.32B	4.44B	4.36B	4.71B	6.28B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	2.69B	4.35B	5.31B	7.62B	9.85B
Total Current Liabilities	18.85B	28.49B	33.04B	36.43B	40.66B
Long-Term Debt	5.3B	8.96B	17.89B	18.17B	16.65B
Long-Term Leases	1M	-	-	7M	14M
Pension & Other Post Retirement Benefits	512M	406M	373M	505M	517M
Deferred Tax Liability Non Current	-	-	105M	997M	653M
Other Non Current Liabilities	261M	211M	280M	482M	529M
Total Liabilities	24.93B	38.07B	51.69B	56.59B	59.02B
Common Stock, Total	982M	982M	982M	982M	982M
Additional Paid In Capital	1.47B	1.47B	1.47B	5.23B	4.92B
Retained Earnings	29.2B	41.51B	61.22B	78.46B	99.72B
Treasury Stock	-54M	-54M	-55M	-3M	-45M
Comprehensive Income and Other	-686M	1.53B	4.69B	7.62B	12.33B
Total Common Equity	30.91B	45.43B	68.31B	92.3B	118B
Minority Interest	3.69B	4.79B	6.49B	7.25B	10.82B
Total Equity	34.6B	50.22B	74.79B	99.55B	129B
Total Liabilities And Equity	59.53B	88.29B	126B	156B	188B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	173M	173M	176M	176M	176M
ECS Total Common Shares Outstanding	-	173M	173M	176M	176M
Book Value / Share	178.87	262.9	395.26	523.81	668.49
Tangible Book Value	30.37B	44.82B	67.66B	87.08B	105B
Tangible Book Value Per Share	175.73	259.35	391.54	494.18	597.01
Total Debt	16.77B	20.88B	32.82B	34.51B	31.61B
Net Debt	-57M	-2.75B	4.53B	-3.44B	-31.38B
Debt Equivalent of Unfunded Proj. Benefit Obligation	246M	116M	-122M	-162M	-71M
Minority Interest, Total (Incl. Fin. Div)	3.69B	4.79B	6.49B	7.25B	10.82B
Inventories - Raw Materials, Total	6.31B	14.66B	25.99B	33.87B	29.76B
Inventories - Work In Process, Total	3.68B	6.02B	14.07B	12.54B	12.7B
Inventories - Finished Goods, Total	1.12B	1.74B	2.78B	6.87B	6.7B
Inventories - Others	2M	1M	-	-	-
Full Time Employees	2.47K	3.67K	4.37K	4K	4.4K
Accumulated Allowance for Doubtful Accounts (Supple)	54M	53M	12M	10M	128M
Order Backlog	18.45B	51.82B	56.88B	63.97B	58.86B

Fiscal Period: February	2021	2022	2023	2024	2025
Net Income	8.94B	18.48B	30.35B	27.07B	32.56B
Depreciation & Amortization - CF	1.29B	1.52B	1.98B	2.55B	2.85B
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	257M	1.69B
Depreciation & Amortization, Total	1.29B	1.52B	1.98B	2.8B	4.54B
(Gain) Loss From Sale Of Asset	-8M	-734M	-9M	10M	313M
(Gain) Loss on Sale of Investments - (CF)	-370M	68M	-	-	2.17B
Other Operating Activities, Total	-2.05B	-2.38B	-6.99B	-7.93B	-8.2B
Change In Accounts Receivable	111M	-7.1B	-8.6B	1.23B	-3.64B
Change In Inventories	-4M	-10.48B	-16.8B	-6.1B	9.33B
Change In Accounts Payable	-402M	4.04B	-186M	-1.6B	567M
Change in Other Net Operating Assets	643M	-403M	-1.66B	61M	-852M
Cash from Operations	8.16B	3.02B	-1.92B	15.54B	36.79B
Capital Expenditure	-2.32B	-2.04B	-4.51B	-1.22B	-1.95B
Sale of Property, Plant, and Equipment	141M	1.99B	29M	4M	-
Cash Acquisitions	-	-	-	-1.78B	-1.19B
Sale (Purchase) of Intangible assets	-126M	-76M	-62M	-84M	-252M
Investment in Marketable and Equity Securities, Total	-21M	-482M	-21M	-1.56B	-2.12B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-274M	-272M	-7M	-1.19B	-555M
Other Investing Activities, Total	-58M	-33M	-580M	-75M	-389M
Cash from Investing	-2.66B	-916M	-5.15B	-5.91B	-6.46B
Short Term Debt Issued, Total	-	1B	350M	31M	-
Long-Term Debt Issued, Total	3B	9.1B	18.2B	11B	3.92B
Total Debt Issued	3B	10.1B	18.55B	11.03B	3.92B
Short Term Debt Repaid, Total	-443M	-	-	-	-1.18B
Long-Term Debt Repaid, Total	-3.48B	-6B	-6.66B	-9.44B	-9.03B
Total Debt Repaid	-3.93B	-6B	-6.66B	-9.44B	-10.21B
Repurchase of Common Stock	-	-	-	-	-441M
Common Dividends Paid	-518M	-518M	-1.12B	-2.33B	-2.38B
Common & Preferred Stock Dividends Paid	-518M	-518M	-1.12B	-2.33B	-2.38B
Other Financing Activities, Total	-4M	-3M	-21M	-47M	-56M
Cash from Financing	-1.45B	3.58B	10.74B	-792M	-9.16B
Foreign Exchange Rate Adjustments	-62M	1.13B	989M	815M	2.2B
Miscellaneous Cash Flow Adjustments	-1M	-	-	-1M	-1M
Net Change in Cash	3.99B	6.81B	4.66B	9.66B	23.38B
Supplemental Items
Cash Interest Paid	45M	40M	50M	70M	79M
Cash Income Tax Paid (Refund)	2.04B	2.37B	6.99B	7.92B	8.21B
Levered Free Cash Flow	4.53B	-1.26B	-13.44B	8.03B	27.57B
Unlevered Free Cash Flow	4.55B	-1.24B	-13.41B	8.08B	27.63B
Change In Net Working Capital	111M	10.52B	27.33B	8.51B	-5.28B
Net Debt Issued / Repaid	-927M	4.1B	11.89B	1.59B	-6.28B

Fiscal Period: February	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.19	13.37	15.38	10.68	11.64
Return on Total Capital	11.92	16.14	18.48	12.49	13.6
Return On Equity %	21.91	32.59	36.31	23.04	20.27
Return on Common Equity	23	33.59	37.6	24.38	22.49
Margin Analysis
Gross Profit Margin %	28.97	33.79	36.82	37.81	39.88
SG&A Margin	8.88	7.89	7.1	10	12.27
EBITDA Margin %	20.87	25.87	30.04	28.89	29.39
EBITA Margin %	18.33	23.6	27.95	26.16	27.1
EBIT Margin %	18.33	23.6	27.95	25.89	25.74
Income From Continuing Operations Margin %	13.63	20.63	24.01	21.54	18.6
Net Income Margin %	12.74	19.14	22.62	20.99	19
Net Avail. For Common Margin %	12.74	19.14	22.62	20.99	19
Normalized Net Income Margin	9.31	15.32	18.87	17.68	18.62
Levered Free Cash Flow Margin	8.91	-1.88	-14.22	8.61	22.16
Unlevered Free Cash Flow Margin	8.96	-1.85	-14.19	8.66	22.21
Asset Turnover
Asset Turnover	0.89	0.91	0.88	0.66	0.72
Fixed Assets Turnover	3.07	3.93	4.78	4.17	5.29
Receivables Turnover (Average Receivables)	4.5	4.44	4.15	3.51	4.36
Inventory Turnover (Average Inventory)	3.17	2.65	1.83	1.21	1.46
Short Term Liquidity
Current Ratio	2.12	2.33	3.03	3.3	3.58
Quick Ratio	1.49	1.49	1.66	1.77	2.3
Operating Cash Flow to Current Liabilities	0.43	0.11	-0.06	0.43	0.9
Days Sales Outstanding (Average Receivables)	81.12	82.12	87.99	104.32	83.62
Days Outstanding Inventory (Average Inventory)	115.08	137.97	199.45	303.32	249.98
Average Days Payable Outstanding	29.11	31.04	32.34	36.74	36.34
Cash Conversion Cycle (Average Days)	167.09	189.05	255.1	370.9	297.26
Long Term Solvency
Total Debt/Equity	48.46	41.59	43.89	34.67	24.56
Total Debt / Total Capital	32.64	29.37	30.5	25.74	19.72
LT Debt/Equity	15.31	17.84	23.92	18.26	12.94
Long-Term Debt / Total Capital	10.31	12.6	16.62	13.56	10.39
Total Liabilities / Total Assets	41.87	43.12	40.87	36.24	31.44
EBIT / Interest Expense	211.68	416.05	539.14	344.84	320.25
EBITDA / Interest Expense	241	456.08	579.55	384.9	365.62
(EBITDA - Capex) / Interest Expense	188.27	402.39	487.51	367.5	346.16
Total Debt / EBITDA	1.58	1.21	1.16	1.28	0.86
Net Debt / EBITDA	-0.01	-0.16	0.16	-0.13	-0.86
Total Debt / (EBITDA - Capex)	2.02	1.37	1.37	1.34	0.91
Net Debt / (EBITDA - Capex)	-0.01	-0.18	0.19	-0.13	-0.91
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	36.92	31.89	41.06	-1.34	33.42
Gross Profit, 1 Yr. Growth %	10.82	53.8	53.74	1.3	40.73
EBITDA, 1 Yr. Growth %	21.83	63.44	63.86	-5.12	35.7
EBITA, 1 Yr. Growth %	20.27	69.74	67.1	-7.65	38.2
EBIT, 1 Yr. Growth %	20.27	69.74	67.1	-8.63	32.67
Earnings From Cont. Operations, 1 Yr. Growth %	25.56	99.7	64.2	-11.5	15.18
Net Income, 1 Yr. Growth %	18.28	98.21	66.75	-8.46	20.73
Normalized Net Income, 1 Yr. Growth %	0.97	117.15	73.7	-7.54	40.53
Diluted EPS Before Extra, 1 Yr. Growth %	18.21	98.17	66.74	-10.2	20.81
Accounts Receivable, 1 Yr. Growth %	-0.08	67.11	41.61	-0.99	15.54
Inventory, 1 Yr. Growth %	-4.49	101.75	91.01	24.4	-7.75
Net Property, Plant and Equip., 1 Yr. Growth %	1.5	4.95	26.43	2.35	8.09
Total Assets, 1 Yr. Growth %	8.68	48.31	43.26	23.45	20.24
Tangible Book Value, 1 Yr. Growth %	22.58	47.58	50.97	28.69	20.92
Common Equity, 1 Yr. Growth %	21.97	46.98	50.34	35.12	27.74
Cash From Operations, 1 Yr. Growth %	22.5	-63.03	-163.66	-909.58	136.69
Capital Expenditures, 1 Yr. Growth %	-59.36	-12.07	121.08	-72.99	59.77
Levered Free Cash Flow, 1 Yr. Growth %	351.15	-127.87	965.43	-159.77	243.22
Unlevered Free Cash Flow, 1 Yr. Growth %	344.75	-127.18	983.4	-160.23	242.13
Dividend Per Share, 1 Yr. Growth %	-	-	107.69	0	25.93
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	27.26	34.38	36.4	17.97	14.73
Gross Profit, 2 Yr. CAGR %	18.12	30.55	53.77	24.8	19.4
EBITDA, 2 Yr. CAGR %	28.5	41.11	63.65	24.68	13.47
EBITA, 2 Yr. CAGR %	26.58	42.88	68.42	24.22	12.97
EBIT, 2 Yr. CAGR %	26.58	42.88	68.42	23.56	10.1
Earnings From Cont. Operations, 2 Yr. CAGR %	26.17	58.35	81.08	20.55	0.97
Net Income, 2 Yr. CAGR %	21.3	53.12	81.8	23.55	5.13
Normalized Net Income, 2 Yr. CAGR %	11.19	48.07	94.21	26.73	13.99
Diluted EPS Before Extra, 2 Yr. CAGR %	21.21	53.05	81.78	22.36	4.16
Accounts Receivable, 2 Yr. CAGR %	20.25	29.22	53.83	18.41	6.96
Inventory, 2 Yr. CAGR %	-11.11	38.81	96.31	54.15	7.13
Net Property, Plant and Equip., 2 Yr. CAGR %	19.65	3.21	15.19	13.76	5.18
Total Assets, 2 Yr. CAGR %	11.96	26.96	45.76	32.98	21.83
Tangible Book Value, 2 Yr. CAGR %	22.12	34.5	49.27	39.39	24.74
Common Equity, 2 Yr. CAGR %	22.49	33.89	48.65	42.53	31.38
Cash From Operations, 2 Yr. CAGR %	133.66	-32.7	-51.48	127.02	337.74
Capital Expenditures, 2 Yr. CAGR %	-27.9	-40.22	39.43	-22.73	-34.31
Levered Free Cash Flow, 2 Yr. CAGR %	-15.8	12.13	72.31	152.35	43.23
Unlevered Free Cash Flow, 2 Yr. CAGR %	-15.44	9.94	71.59	155.45	43.55
Dividend Per Share, 2 Yr. CAGR %	-	47.2	-	44.12	12.22
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.93	28.79	36.57	22.44	22.91
Gross Profit, 3 Yr. CAGR %	16.79	28.98	37.86	33.8	29.9
EBITDA, 3 Yr. CAGR %	30.76	39.23	48.32	36.46	28.25
EBITA, 3 Yr. CAGR %	29.67	39.59	50.54	37.85	28.72
EBIT, 3 Yr. CAGR %	30.03	39.59	50.54	37.36	26.53
Earnings From Cont. Operations, 3 Yr. CAGR %	33.37	47.04	60.27	42.64	18.73
Net Income, 3 Yr. CAGR %	33.11	42.87	57.53	44.63	22.6
Normalized Net Income, 3 Yr. CAGR %	25.91	38.98	56.17	51.65	31.17
Diluted EPS Before Extra, 3 Yr. CAGR %	33.05	42.79	57.49	43.7	21.84
Accounts Receivable, 3 Yr. CAGR %	13.49	34.2	33.22	32.82	17.45
Inventory, 3 Yr. CAGR %	14.42	16.81	54.4	68.61	29.9
Net Property, Plant and Equip., 3 Yr. CAGR %	28.19	14.53	10.43	10.74	11.84
Total Assets, 3 Yr. CAGR %	20.64	22.96	32.17	37.91	28.59
Tangible Book Value, 3 Yr. CAGR %	21.88	30.08	39.78	42.07	32.94
Common Equity, 3 Yr. CAGR %	22.01	30.16	39.16	44	37.42
Cash From Operations, 3 Yr. CAGR %	571	26.38	-33.94	23.98	130.2
Capital Expenditures, 3 Yr. CAGR %	7.72	-22.97	-7.56	-19.33	-1.56
Levered Free Cash Flow, 3 Yr. CAGR %	20.72	-41.76	137.49	21.07	179.59
Unlevered Free Cash Flow, 3 Yr. CAGR %	21.26	-42.08	135.71	21.04	181.58
Dividend Per Share, 3 Yr. CAGR %	-	37.51	65.1	-	37.78
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	20.57	22.05	12.59	24.35	27.38
Gross Profit, 5 Yr. CAGR %	19.32	23.12	30.38	27.29	30.16
EBITDA, 5 Yr. CAGR %	26.11	28.42	43.04	33.22	33.25
EBITA, 5 Yr. CAGR %	25.96	28.16	43.96	33.22	34.21
EBIT, 5 Yr. CAGR %	25.96	28.16	44.21	32.94	32.83
Earnings From Cont. Operations, 5 Yr. CAGR %	25.28	33.65	50.72	35.81	33.23
Net Income, 5 Yr. CAGR %	24.52	33.23	50.79	34.81	34
Normalized Net Income, 5 Yr. CAGR %	20.66	30.78	49.75	33.95	37.69
Diluted EPS Before Extra, 5 Yr. CAGR %	24.48	33.18	50.74	34.24	33.48
Accounts Receivable, 5 Yr. CAGR %	14.02	20.87	28.17	27.64	22.02
Inventory, 5 Yr. CAGR %	19.7	35.92	42	30.52	33.4
Net Property, Plant and Equip., 5 Yr. CAGR %	22.65	21.71	22.82	14.22	8.3
Total Assets, 5 Yr. CAGR %	21.49	26.76	30.12	26.87	27.94
Tangible Book Value, 5 Yr. CAGR %	21.83	26.31	32.17	33.72	33.56
Common Equity, 5 Yr. CAGR %	21.75	26.23	32.04	34.97	36
Cash From Operations, 5 Yr. CAGR %	48.04	-3.81	134.63	59.75	40.76
Capital Expenditures, 5 Yr. CAGR %	45.08	13.21	19.43	-22.87	-19.37
Levered Free Cash Flow, 5 Yr. CAGR %	57.32	-10.76	39.18	4.7	94
Unlevered Free Cash Flow, 5 Yr. CAGR %	56.36	-11.19	39.32	4.87	93.3
Dividend Per Share, 5 Yr. CAGR %	-	26.58	46.51	40.11	41.47